Pancreatic Cancer Research

ResearcherErasmus MCActive in the last 2 years

Lara Rosaline Heij

Matched on ORCID iD 0000-0002-0602-3356; OpenAlex author ID A5008499568. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
59
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: 3 papers · 2026: 2 papers

Papers 14

  1. In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment. Co-author DOI 10.1016/j.celrep.2025.116827↗
  2. Spatial Proteomics Uncovers Immune Cell Neighborhoods and Tumor-Immune Interfaces in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.mcpro.2026.101697↗
  3. Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms. Co-author DOI 10.1038/s41467-024-55424-2↗
  4. Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. Last author DOI 10.1038/s41598-025-94362-x↗
  5. Perineural Invasion is an Important Prognostic Factor in Patients With Radically Resected (R0) and Node-negative (pN0) Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006320↗
  6. ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration. Co-author DOI 10.1002/1878-0261.13609↗
  7. The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survival. Co-author DOI 10.1016/j.pan.2024.08.014↗
  8. Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells. Co-author DOI 10.1016/j.isci.2023.106324↗
  9. Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Co-author DOI 10.3390/cancers15030683↗
  10. Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma. Last author DOI 10.1038/s41388-020-01578-4↗
  11. Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer. Co-author DOI 10.3390/cancers13081776↗
  12. Nerve Fibers in the Tumor Microenvironment Are Co-Localized with Lymphoid Aggregates in Pancreatic Cancer. Co-author DOI 10.3390/jcm10030490↗
  13. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia. Co-author DOI 10.1002/jcsm.12627↗
  14. Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes. Co-author DOI 10.1002/ijc.32186↗

Closest collaborators

The 25 strongest of 59 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shivan Sivakumar · 9 shared papers, 2019–2026 · strength 1.39
  2. Georg J. Wiltberger · 5 shared papers, 2021–2025 · strength 0.74
  3. Rachael J. M. Bashford-Rogers · 4 shared papers, 2021–2026 · strength 0.63
  4. Edgar Dahl · 3 shared papers, 2023–2025 · strength 0.55
  5. Bas Groot Koerkamp · 3 shared papers, 2024–2025 · strength 0.54
  6. Michael Loran Dustin · 4 shared papers, 2019–2025 · strength 0.54
  7. Ashwin Jainarayanan · 3 shared papers, 2021–2025 · strength 0.44
  8. Xiuxiang Tan · 3 shared papers, 2021–2025 · strength 0.40
  9. Casper H.J. van Eijck · 2 shared papers, 2024–2025 · strength 0.37
  10. Michail Doukas · 2 shared papers, 2025 · strength 0.36
  11. Sophia Villwock · 2 shared papers, 2023–2024 · strength 0.36
  12. Maximilian Hauschulz · 2 shared papers, 2023–2024 · strength 0.36
  13. Jennifer R. Kosinski · 2 shared papers, 2023–2024 · strength 0.36
  14. Adam Enver Frampton · 2 shared papers, 2023–2025 · strength 0.33
  15. Steven W.M. Olde Damink · 3 shared papers, 2020–2021 · strength 0.32
  16. Merel R. Aberle · 3 shared papers, 2020–2021 · strength 0.32
  17. Tom Luedde · 2 shared papers, 2021–2025 · strength 0.30
  18. Judith de Vos‐Geelen · 2 shared papers, 2021–2025 · strength 0.29
  19. Garry Nolan · 1 shared paper, 2026 · strength 0.26
  20. Sizun Jiang · 1 shared paper, 2026 · strength 0.26
  21. Jason Yeung · 1 shared paper, 2026 · strength 0.26
  22. Sven Arke Lang · 2 shared papers, 2021 · strength 0.21
  23. Evelien J.M. de Jong · 1 shared paper, 2025 · strength 0.19
  24. Wolfram Trudo Knoefel · 1 shared paper, 2025 · strength 0.19
  25. Anna Lyubetskaya · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.